BSE filing, NSE: NEULANDLAB. Summary written from the filing by ALFA Finder's alert engine.
Neuland Laboratories Ltd: key numbers
- Share price
- ₹19,424.00
- Market cap
- ₹24,921 Cr
- Revenue (annual)
- ₹2,023 Cr
- Net profit (annual)
- ₹364.0 Cr
- P/E (TTM)
- 50.1×Sector 47.2×
- Promoter holding
- 32.26%-0.36% QoQ
- FII holding
- 21.93%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Neuland Laboratories Ltd
All →Neuland Laboratories Investor Presentation: Key Takeaways
Q2FY27 income Rs457.2 Cr (-11.4% YoY), PAT Rs51.1 Cr (-47.0%), EBITDA margin 22.9% on operating deleverage. H1FY27 income Rs1107.2 Cr (+35.6%), PAT Rs198.5 Cr (+80.2%). Capex-led R&D and peptide build-out.
Neuland Laboratories Q2 FY27 Results: Net Profit ₹51.6 Cr, Down 46.7% YoY
Neuland Laboratories Ltd reported revenue from operations of ₹449.7 Cr (-12.6% YoY) and net profit of ₹51.6 Cr (-46.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹51.6 Cr · -46.7% YoY
Neuland Laboratories Other Announcement
Neuland Laboratories notified loss of 100 share certificates by shareholder Madan Mohan Singh. The company requested issuance of an entitlement letter in lieu of the lost certificates.
Neuland Laboratories Board Meeting Date
Neuland Laboratories will hold a board meeting on November 3, 2026, to consider and approve the unaudited financial results for the quarter ended September 30, 2026.
Neuland Laboratories Business Update
Neuland Laboratories' Unit 3 manufacturing facility received an Establishment Inspection Report from the US FDA. The agency has officially closed the inspection.
Neuland Laboratories Other Announcement
Neuland Laboratories Ltd has submitted its quarterly shareholding pattern for the quarter ended September 30, 2026, in compliance with SEBI Regulation 31.
Other results update announcements
All →Awfis Space Solutions Results Update
Awfis reported Q2 FY27 normalised revenue up 26% to Rs 451 Crore; cash EBITDA rose 45% to Rs 49 Crore. Strong co-working and GCC demand drove growth.
Anthem Biosciences Results Update
Anthem Biosciences reported Q2 FY27 consolidated revenue of ₹5,940 Mn, up 7.9% year-on-year, and PAT of ₹2,115 Mn. H1 FY27 PAT rose 7.2% to ₹3,314 Mn.
Aayush Wellness Results Update
Aayush Wellness reported H1 FY27 consolidated total income of ₹7,061.82 lakhs, up 10.61%. PAT rose 5.86% to ₹250.10 lakhs.
Bata India Results Update
Bata India reported Q2 revenue of Rs. 8,618 million, up 7.5%, and PAT of Rs. 180 million, up 31%. Growth continued for a fourth consecutive quarter.
Asian Granito India Results Update
Asian Granito India's press release reports consolidated Q2 FY27 revenue up 18.8% to ₹528.5 Crore. Profit after tax fell to ₹5.22 Crore amid a sharp rise in power and fuel costs.
National Stock Exchange of India Results Update
NSE's press release reports Q2 FY27 consolidated PAT up 23% YoY to ₹2,578 crore. Total income rose 9% to ₹4,554 crore alongside the audited results.